NR4A1 and neoplasm: Indeed, studies on the breast cancer tumor microenvironment (TME) suggest that hormone receptor-positive breast tumors may be immunologically “colder” than their triple-negative and human epidermal development element receptor 2 (HER2)-positive counterparts [18].